Carbios Doubles Its Number of Granted Patents in Two Years for Its Proprietary Enzymatic Technologies
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228006180/en/
Carbios patent tiles by geographic region (Graphic: Carbios)
Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles, has doubled its number of issued patents since the last review published at the end of 20201.
Protection of Carbios’ processes
Carbios (and its subsidiary Carbiolice) currently holds 336 titles worldwide divided into 53 patent families. In 2022, several titles protecting the proprietary PET-degrading enzymes were granted in countries of interest such as the United States and also in Asian countries including Indonesia, South Korea, China, Japan and India. Carbios has also obtained grants within its patent families protecting the biodegradable plastics production process, notably the masterbatch containing the enzyme or its production process.
"Over the past two years, we have mainly focused on strengthening the protection of our PET biorecycling process and its proprietary enzymes," commented Lise LUCCHESI, Director of Intellectual Property at Carbios. "For the coming years, we will continue to consolidate the protection of this process, and that of our PLA biodegradation process, by filing new patent applications. We will also actively follow up on our filed patent applications in order to obtain granted patents."
"Since the beginning of Carbios, the R&D and Intellectual Property departments have worked hand in hand to ensure maximum protection of our enzymes and processes," commented Alain Marty, Chief Scientific Officer at Carbios. "These continued efforts to obtain extensive international protection are crucial to safeguard our innovations and ensure the industrial deployment of our technologies."
Carbios is expanding its intellectual property portfolio in regions and countries where there is strong demand for its disruptive technologies (see Fig. 1), notably :
- in Europe: 40 European titles, which could be granted in the 39 member states of the European Patent Organization
- in North America: 41 titles in the United States and 23 in Canada
- in Asia: 152 titles, including 37 in China, 27 in Japan and 24 in India
Carbios also has 14 patent applications that may be extended to other countries or regions of the world in the coming years.
"We are convinced that biological recycling is the most efficient and circular solution to degrade plastics," stated Emmanuel LADENT, CEO of Carbios. "The protection of our enzymes and processes is at the heart of our work, and we have a dedicated Intellectual Property team within Carbios. From 2023, we will also focus our efforts on protecting innovation related to enzymatic degradation of other polymers."
A dedicated Intellectual Property team
The Intellectual Property team at Carbios includes a Director (who is also a member of the Executive Committee) and two patent engineers specialized in the fields of biotechnology and polymer chemistry, one of whom is a representative before the European Patent Office. The team is supported by two external Intellectual Property consulting firms (Becker & Associés and Franck Tetaz Intellectual Property). Finally, an Intellectual Property Committee reports regularly to Carbios’ Board of Directors.
Established in 2011 by Truffle Capital, Carbios is a green biotech company, developing biological and innovative processes. Through its unique approach of combining enzymes and plastics, Carbios aims to address new consumer expectations and the challenges of a broad ecological transition by taking up a major challenge of our time: plastic and textile pollution. Carbios deconstructs any type of PET (the dominant polymer in bottles, trays, textiles made of polyester) into its basic components which can then be reused to produce new PET plastics with equivalent quality to virgin ones. This PET innovation, the first of its kind in the world, was recently recognized in a scientific paper published in front cover of the prestigious journal Nature. Carbios successfully started up its demonstration plant in Clermont-Ferrand in 2021. It has now taken another key step towards the industrialization of its process with the construction of a first-of-a-kind unit in partnership with Indorama Ventures.
In 2017, Carbios and L’Oréal co-founded a consortium to contribute to the industrialization of its proprietary recycling technology. Committed to developing innovative solutions for sustainable development, Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe joined this consortium in April 2019. In 2022, Carbios signed an agreement with On, Patagonia, PUMA, and Salomon, to develop solutions promoting the recyclability and circularity of their products. PVH Corp. joined this consortium in January 2023.
The Company has also developed an enzymatic biodegradation technology for PLA-based (a bio sourced polymer) single-use plastics. This technology can create a new generation of plastics that are 100% compostable at ambient temperatures, even in domestic conditions, integrating enzymes at the heart of the plastic product.
For more information, please visit carbios.com / Twitter: Carbios / LinkedIn: Carbios / Instagram: insidecarbios
Carbios (ISIN FR0011648716/ALCRB) is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in France, in Europe, in the United States or in any other country.
In case of discrepancy between the French and the English version of this press release, the French version shall prevail.
1 Cf. press release dated 14 January 2021
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006180/en/
+33 (0)4 73 86 51 76
Press Relations (France)
+33 (0)1 44 14 99 96
Press Relations (U.S.)
Kate L. Barrette
+1 212 223 0561
Press Relations (DACH & UK)
+49 (0)211 529 252 22
About Business Wire
24 Martin Lane
EC4R 0DR London
+44 20 7626 1982http://www.businesswire.co.uk
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Africell Angola Races Towards 10 Million Subscribers Using Csmart Digital BSS Platform27.3.2023 16:21:00 CEST | Press release
Within 8 months of launching services in Angola, Africell already has over 7 million subscribers. To achieve such rapid progress, Africell needed a new-age digital solution that would help execute its market timelines and provide reliable services across its expanding Angola footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230326005092/en/ Africell’s vision of bringing new products to market which make a positive difference to customers has been facilitated by Csmart, a digital BSS platform built to meet the growth requirements of innovative telecoms players like Africell. The solution - which is built on TM Forum’s ODA and Open API standards - helps customers monetize any business model, network, service, and experience at scale. “We are committed to delivering on Africell’s vision of affordability, reliability and customer experience,” says CEO of Covalense Digital, Sreenivas Peesapati, adding that “Csmart would c
United in Purpose: CSG Launches Inaugural Impact Report27.3.2023 15:30:00 CEST | Press release
CSG® (NASDAQ: CSGS) today published its inaugural Impact Report, United in Purpose, which highlights its progress in diversity, inclusion, social impact and sustainability initiatives. The report details CSG’s efforts over the past year to help drive a positive impact and uplift the communities in which the company operates. “CSG’s inaugural impact report underscores that we are, at every level, a purpose-driven company,” said Brian Shepherd, president and CEO, CSG. “With a globally diverse workforce of more than 5,700 CSGers serving customers in 120 countries, CSG has both the opportunity and responsibility to make a bigger difference in everything we do. CSG will continue to champion transparency and provide reliable environmental, social, and governance data as we work to envision, invent, and shape a better, more future-ready world.” CSG’s metrics of success are linked to its customer obsession, diverse and inclusive culture, commitment to social impact, and pursuit of growth acros
Nine-Time Emmy Winner, Eric Black, Named Edgio’s CTO/General Manager of Media27.3.2023 15:05:00 CEST | Press release
Edgio, Inc. (Nasdaq: EGIO), the platform of choice for speed, security and simplicity at the edge, today announced it has appointed Eric Black as CTO/General Manager, Media. Having been at the forefront of digital video and live event streaming with NBC Universal for more than twenty years, Black joins Edgio to lead the company’s growth in delivering the highest quality linear, live and on-demand video experiences, to every device worldwide. Prior to joining Edgio, Black led NBC Universal’s media technology strategy across a host of digital properties during pivotal moments in the evolution of live streaming. He managed the first-ever live stream of a Super Bowl in 2010, delivered six Olympic Games (including the Rio 2016 Olympic Games, the largest digital event in history at the time), 2018 FIFA World Cup, and Presidential debates. He also guided the team that launched NBC Universal’s Peacock in 2020. The systems built by Black have focused on both high concurrent traffic and scale, a
ASM Global Unveils Ambitious Plan Transforming Its Global Venue Portfolio Into World’s Most Sustainable Collection27.3.2023 15:00:00 CEST | Press release
ASM Global, through its corporate social responsibility platform, ASM Global Acts, and in partnership with Honeycomb Strategies, has announced a dramatic plan—the most aggressive in the live entertainment industry—to convert its portfolio into the most sustainable venues on Earth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005195/en/ Colorado Convention Center / Photo courtesy of ASM Global Beginning this year ASM Global will dedicate its full resources to achieving measurable results throughout its businesses using the most comprehensive tracking system in the venue space—intended to reflect that scale and create substantial collective impact on every continent it operates. The company working with its client partners already boasts the largest collection of certified green venues with over 40 and growing throughout the portfolio. In making the announcement, ASM Global President and CEO Ron Bension said, “Our curr
Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO ® (avelumab)27.3.2023 14:00:00 CEST | Press release
Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer. “On behalf of Merck, I’d like to thank Pfizer for their partnership and collaboration over the last nine years, and for the role they have played in the success of BAVENCIO,” said Belén Garijo, Chair of the Executive Board and CEO of Merck. “Our joint efforts have delivered meaningful therapeutic value to patients around the world who are living with cancer. This has been an incredible journey for us, and thanks to Pfizer’s partnership we are now very well positioned to continue to deliver this therapy to patients in need.” “Our alliance with Merck allowed us to combine our complementary strengths to develop and launch BAVENCIO to help meet the needs of people with cancer globally,” said Dr. Albert Bourla,